Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial
References (79)
- et al.
Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months
J Diabetes Complications
(1992) - et al.
The role of protein kinase C in the development of the complications of diabetes
Vitam Horm
(2000) - et al.
Development and validity testing of the Neuropathy Total Symptom Score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy
Clin Ther
(2005) The McGill Pain Questionnaire: Major properties and scoring methods
Pain
(1975)- et al.
Progression rates of diabetic neuropathy in placebo patients in an 18-month clinical trial
J Diabetes Complications
(1998) - et al.
Walking stability and sensorimotor function in older people with diabetic peripheral neuropathy
Arch Phys Med Rehabil
(2004) Diagnosis and management of diabetic neuropathy
Clin Geriatr Med
(1999)- et al.
Sural nerve myelinated fiber density differences associated with meaningful changes in clinical and electrophysiologic measurements
J Neurol Sci
(1996) - et al.
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study
Neurology
(1993) - et al.
Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study
Diabetes
(1989)
Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: The EURODIAB IDDM Complications Study
Diabetologia
(1996)
A multicenter study on the prevalence of diabetic neuropathy in Italy
Diabetes Care
(1997)
A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population
Diabetologia
(1993)
Prevalence of diabetic neuropathy and foot ulceration: Identification of potential risk factors—a population-based study
Wounds
(2002)
Risk factors for amputation in patients with diabetes mellitus. A case-control study
Ann Intern Med
(1992)
Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers
Diabetes Care
(1999)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Lancet
(1998)
Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT)
Diabetes
(1988)
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
N Engl J Med
(1993)
Risk factors for severity of diabetic polyneuropathy: Intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort
Diabetes Care
(1999)
The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)
Diabetologia
(1998)
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
N Engl J Med
(2003)
Diabetic neuropathies: A statement by the American Diabetes Association
Diabetes Care
(2005)
Design of controlled clinical trials for diabetic polyneuropathy
Semin Neurol
(1996)
New developments in the diagnosis of diabetic neuropathy
Am J Med
(1999)
Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: The effects of age, sex, type of diabetes, disease duration, and anthropometric factors
Neurology
(1996)
American Diabetes Association American Academy of Neurology. Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy
Diabetes Care
(1988)
Quantitative measurement of cutaneous perception in diabetic neuropathy
Muscle Nerve
(1995)
Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy
Diabetes Care
(1987)
Microangiopathy in human diabetic neuropathy: Relationship between capillary abnormalities and the severity of neuropathy
Diabetologia
(1989)
Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity
Ann Neurol
(1995)
Distal sensory nerves of the lower extremity in peripheral neuropathy: Comparison of medial dorsal cutaneous and sural nerve abnormalities
Arch Phys Med Rehabil
(1985)
Diabetic neuropathy: Electrophysiologic abnormalities of distal lower extremity sensory nerves
Arch Phys Med Rehabil
(1986)
Clinical utility of dorsal sural nerve conduction studies
Muscle Nerve
(2001)
The usefulness of minimal F-wave latency and sural/radial amplitude ratio in diabetic polyneuropathy
Yonsei Med J
(2000)
Sensory action potentials and biopsy of the sural nerve in neuropathy
Brain
(1978)
LY333531 treatment improves diabetic peripheral neuropathy (DPN) with symptoms
Diabetes
(2002)
Detectable sural nerve action potential (SNAP) identifies patients with early diabetic peripheral neuropathy (DPN)
Diabetes
(2002)
Metabolic and vascular factors in the pathogenesis of diabetic neuropathy
Diabetes
(1997)
Cited by (0)
- *
All MBBQ Study Group principal investigators and sites are listed in the Acknowledgments.
Copyright © 2005 Published by Elsevier Inc.